​​​​​​​China Halts Banks From Selling Commodity-Linked Investment Products To Retail Traders

​​​​​​​China Halts Banks From Selling Commodity-Linked Investment Products To Retail Traders

Now that the inflation narrative has been paralyzed with Bloomberg picking up on what we said last week about China’s tumbling credit impulse… China’s top banking regulator has directed banks to stop selling commodity-linked investments to mom-and-pop buyers, three sources with knowledge of the matter told Reuters. They said China is cracking down on the commodity boom and is attempting to curb future investment losses. 

The China Banking and Insurance Regulatory Commission (CBIRC) requested banks to unwind existing books of commodity-linked products. This comes, as we noted above, China’s credit impulse is plunging and has crossed into negative territory, which will limit upside in global commodity prices. 

The commodity boom began in the spring of 2020, driven by unprecedented monetary support from global central banks and fiscal support from governments, resulting in soaring prices from iron ore to copper to soybeans to wheat to crude to gasoline to almost every commodity. And, of course, Chinese retail traders went wild during the boom, sort of like Chinese farmers who invested their life savings in 2015 only to lose it all when everything crashed. 

“The risk contained in banks’ commodity-linked investments cannot be easily spotted by ordinary investors, neither can they bear it,” one of the sources said. “Banks also don’t have enough expertise to run such products properly.”

CBIRC is moving to curb commodity speculation among retail as state planners and exchanges in recent weeks said they would implement price-control measures for commodities. 

Last weekend, the National Development and Reform Commission (NDRC) cracked down on commodity speculation, threatening top metal firms with severe punishment for price manipulation to excessive speculation to spreading fake news. 

After a year-long vertical rampage, iron-ore futures have hit a sudden air pocket in the last week amid chatter from Chinese regulators. There’s a “zero tolerance” for monopoly behavior and hoarding, the NDRC top execs Sunday. 

“With policy risk-shifting toward government intervention, prices will surely be affected by market sentiment,” said Li Ye, an analyst at Shenyin Wanguo Futures Co. in Shanghai, who Bloomberg quoted. “The rapid surge in commodity prices has badly affected manufacturers and market orders, leading to losses and defaults.”

Over the past few years, we have vehemently explained that ‘as goes China’s credit impulse, so goes the world’, and it would appear, once again, that is occurring. 

With China’s credit impulse negative, mom-and-pop investors who leveraged up in commodity-linked investments could get wiped out again as liquidity eases. 

Sources said some banks are shifting their commodity-linked investments and clients to affiliated brokerages, but this would require permission from the securities regulator. 

The Chinese government also warned that it would monitor and effectively ‘manage’ a rapid increase in commodity prices, without specifying how.

One final reminder: the credit impulse first reaches assets driven primarily by the Chinese economy (Chinese bond yields and industrial metals). Next to be impacted are inflation breakevens and sovereign yields in Western economies. The peak correlation for other growth-sensitive assets such as eurozone banks and AUD/JPY arrives with a bigger lag of around 4-5 quarters. This result, while logical, is quite significant, as it gives us a playbook for the ebb and flow in Chinese credit impulse.

… and it’s possible China is killing the commodity craze

Tyler Durden
Wed, 05/26/2021 – 09:14

via ZeroHedge News https://ift.tt/34jV8xk Tyler Durden

Taper Is Coming: Got Bonds?

Taper Is Coming: Got Bonds?

Authored by Michael Lebowtiz via RealInvestmentAdvice.com,

The solid economic recovery and easing of COVID restrictions lead us to believe a tapering of QE may not be far off. Further supporting our opinion, inflation has fully recovered to pre-pandemic levels, and employment is improving rapidly. On top of that are whispers from within the Fed questioning financial stability given extreme asset valuations driven to some degree by excessive QE.  

Most importantly, various Fed members are starting to talk the taper talk.

The eventual tapering of QE will foster a change in investor behaviors. This article focuses on bond yields and a few interest-rate-sensitive equity sectors to provide forward guidance on how fixed income and interest-rate-sensitive assets may perform in a tapering environment. 

Talking Taper

Jerome Powell repeatedly affirms the Fed “isn’t even thinking about thinking about tapering.” Of course, as Chairman of the Fed, his opinions take precedence over those from other Fed members. Regardless, other Fed members are not entirely on the same page as Powell.

The following comments and headlines came out over the last month.

  • BULLARD: U.S. MAY BE “GETTING CLOSE” TO THE POINT WHERE PANDEMIC IS OVER, THEN ATTENTION COULD TURN TO POST-PANDEMIC MONETARY POLICY

  • Lael Brainard: “Vulnerabilities associated with elevated risk appetite are rising.” The combination of stretched valuations with very high levels of corporate indebtedness bear watching because of the potential to amplify the effects of a repricing event.”

  • Robert Kaplan: “The Fed should start talking about tapering bond-buying soon.” & “I am beginning to feel differently regarding the advantages and drawbacks of the Fed’s QE purchases.”

  • Eric Rosengren: “the mortgage market probably doesn’t need as much support now.

  • It may be that interest rates will have to rise somewhat to make sure our economy doesn’t overheat,” Yellen said in an interview with the Atlantic recorded Monday that was broadcast on the web on Tuesday. “It could cause some very modest increases in interest rates.” – Treasury Secretary Janet Yellen, per Bloomberg.

Other Taper Worthy Factors

Beyond hints from Fed members and robust economic data, banks and the money markets are encountering QE-related problems.

First, banks are struggling to digest the reserves they receive when the Fed purchases assets from them. As a result, their ongoing ability to facilitate additional amounts of QE is increasingly becoming problematic.

Zoltan Pozsar, credit analyst and Fed expert at Credit Suisse, summed the situation as follows:

 “(The) use of the (reverse repurchase program RRP) facility has never been this high outside of quarter-end turns, and the fact that the use of the facility is this high on a sunny day mid-quarter means that banks don’t have the balance sheet to warehouse any more reserves at current spread levels.

The second problem facing the Fed is the recent reduction of Treasury balances held at the Fed. As a result, the Treasury is issuing fewer short-term bonds, resulting in a scarcity of money market securities and collateral supporting derivatives. Consequently, short-term interest rates are starting to go negative.

The two problems make it progressively more challenging to maintain the pace of QE and keep rates from going negative.

QE, Taper, and Bond Yields

With an understanding of our case for tapering, let’s revisit how yields behaved during prior episodes of QE and the periods following QE.  

The graph below shows the yield on ten-year UST notes rose during each QE period and fell upon its conclusion. As circled, yields fell precipitously when the Fed reversed QE via Quantitative Tightening (QT).

Ten-year yields tend to rise about 1% from the start of QE to peak yield levels during QE. Equally important, yields tend to fall toward the end of QE. The reason for peaking before QE ends is growing investor beliefs, at those times, the Fed was getting closer to tapering or halting QE purchases. The jury is still out on QE4.

Currently, yields are close to their cycle highs. If we believe the Fed is nearing tapering, yields could be peaking. Based on prior QE taper experiences, a yield decline of 1% or even more may be in store for the next six months to a year if the Fed is, in fact, on the doorsteps of tapering.

Similarly, the following graph compares the 2yr/10yr yield curve and the Fed’s balance sheet over the same QE periods.  

The yield curve and yield graphs look similar. Short-term yields were relatively constant during QE while long-term yields rose. In all three QE examples, the yield curve quickly flattened after QE ended.

Beyond Bonds

As our confidence in the Fed reducing its pace of QE heightens, our bond allocation and duration of bonds should increase.  That said, we must also consider how other interest-rate-sensitive assets might do. Below we provide a similar analysis for financial stocks (XLF), preferred stocks (PFF), and MBS agency REITs (NLY).

The table below shows the returns of the three assets during QE and the six months following QE.

Profits and/or dividends for the three assets are sensitive to changes in the yield curve. While not concrete, the assets did better during QE when the yield curve was steepening. On average, the three assets gained 28% during each episode of QE. Their performance was not as robust when the yield curve flattened after QE. On average, they fell nearly 2% during the six months following QE.  

When the Fed begins to taper or even get more serious about tapering, we advise caution with exposure to the three assets.

Inflation Expectations

Top of every investor’s mind these days is inflation. As such, it is worth sharing how market expectations for inflation changed during the four periods of QE.

As shown below, QE 1 was accompanied by a 3% spike in inflation expectations, albeit from negative territory. Likewise, QE 2 saw expectations rise while they fell during QE3. 

Thus far, during QE4, they spiked by about 2.50%, like QE1, but starting from a higher level. Of note, implied inflation expectations are now above pre-pandemic expectations. The QE1 spike in expectations failed to clear prior expectations.

The Fed, via QE, makes this analysis incredibly difficult. As shown below, the Fed is an active buyer in the TIPs market, thereby distorting implied inflation readings. The indicator is not worthless, but it is flawed, making comparisons to the past more difficult. We offer caution when considering inflation expectations into your yield forecast.

Summary

We know it may sound crazy to stock investors when we say “fade the Fed.” The stock market has taught equity investors to buy when the Fed is buying and be careful when they are not. What stock investors may not know is the poor performance of bonds during QE and their strong performance afterward.

Bond investors should sell when the Fed is buying and buy when they are selling.

The Fed is potentially on the precipice of tapering their asset purchases. How they might accomplish that and when are big unknowns. However, it is coming, and there is a good amount of money to be made or not lost when the market senses the Fed is ready to change its tune.

Tyler Durden
Wed, 05/26/2021 – 08:55

via ZeroHedge News https://ift.tt/3hTWEOF Tyler Durden

Bezos Buys Bond – Amazon Acquires MGM For $8.45 Billion

Bezos Buys Bond – Amazon Acquires MGM For $8.45 Billion

Confirming earlier leaked details, Amazon has agreed to buy the nearly century-old Metro-Goldwyn-Mayer movie studio for $8.45 billion, according to a statement.

“MGM has nearly a century of filmmaking history and complements the work of Amazon Studios, which has primarily focused on producing TV show programming”

Bezos, Jeff Bezos.

Full Press Release:

Amazon (NASDAQ: AMZN) and MGM today announced that they have entered into a definitive merger agreement under which Amazon will acquire MGM for a purchase price of $8.45 billion. MGM has nearly a century of filmmaking history and complements the work of Amazon Studios, which has primarily focused on producing TV show programming. Amazon will help preserve MGM’s heritage and catalog of films, and provide customers with greater access to these existing works. Through this acquisition, Amazon would empower MGM to continue to do what they do best: great storytelling.

“MGM has a vast catalog with more than 4,000 films – 12 Angry Men, Basic Instinct, Creed, James Bond, Legally Blonde, Moonstruck, Poltergeist, Raging Bull, Robocop, Rocky, Silence of the Lambs, Stargate, Thelma & Louise, Tomb Raider, The Magnificent Seven, The Pink Panther, The Thomas Crown Affair, and many other icons – as well as 17,000 TV shows – including Fargo, The Handmaid’s Tale, and Vikings—that have collectively won more than 180 Academy Awards and 100 Emmys,” said Mike Hopkins, Senior Vice President of Prime Video and Amazon Studios. “The real financial value behind this deal is the treasure trove of IP in the deep catalog that we plan to reimagine and develop together with MGM’s talented team. It’s very exciting and provides so many opportunities for high-quality storytelling.”

“It has been an honor to have been a part of the incredible transformation of Metro Goldwyn Mayer. To get here took immensely talented people with a true belief in one vision. On behalf of the Board, I would like to thank the MGM team who have helped us arrive at this historic day,” said Kevin Ulrich, Chairman of the Board of Directors of MGM. “I am very proud that MGM’s Lion, which has long evoked the Golden Age of Hollywood, will continue its storied history, and the idea born from the creation of United Artists lives on in a way the founders originally intended, driven by the talent and their vision. The opportunity to align MGM’s storied history with Amazon is an inspiring combination.”

Completion of this transaction is subject to regulatory approvals and other customary closing conditions.

MGM shares are up modestly on the headlines having priced it all in earlier in the week…

Citi analysts said previously that buying MGM “will ensure Amazon has access to high-quality content as more media firms accelerate their direct-to-consumer pivot,” and it “will likely distance Amazon’s Prime service from rivals that will (or do) offer a similar service.”

But, as Rabobank’s Michael Every noted, In short, while there is a critical shortage of content for the streaming screen time we are all embracing, I am not sure if the real solution comes from the supply side, rather than just watching less rubbish.

Tyler Durden
Wed, 05/26/2021 – 08:43

via ZeroHedge News https://ift.tt/3fm0nTu Tyler Durden

Ford Reveals That 4 Out Of 10 Cars It Sells In 2030 Will Be Electric

Ford Reveals That 4 Out Of 10 Cars It Sells In 2030 Will Be Electric

Ford’s hopes to follow in Tesla’s and GM’s footsteps and piggyback on the EV/ESG bandwagon will be tested this morning, with Ford stock spiking then sliding in jittery trade after Ford confirmed yesterday’s Reuters rumor that the company would boost spending on electric vehicles by at least 36% to $30 billion and said that  40% of Ford global vehicle volume to be all-electric by 2030;

Ford also said it is creating a commercial vehicles service and distribution business to be known as FordPro to generate a recurring revenue stream. Moving away form a single transaction business model — where all revenue comes from the sale of a car — will help the automaker realize an 8% operating margin by 2023, it said in a statement.

The announcement comes ahead of its Capital Markets Day meeting with investors, in which among other things, Ford explains how it will “lead the electrification revolution”:

“This is our biggest opportunity for growth and value creation since Henry Ford started to scale the Model T, and we’re grabbing it with both hands,” Chief Executive Officer Jim Farley said in the statement.

Ford stock was volatile in response, first rising then dropping to session lows, before the algos realized that all of this had been leaked previously.

Tyler Durden
Wed, 05/26/2021 – 08:25

via ZeroHedge News https://ift.tt/3fNDYxf Tyler Durden

Biden Shut Down Wuhan Lab Investigation Probing COVID-19 Origins: Report

Biden Shut Down Wuhan Lab Investigation Probing COVID-19 Origins: Report

The Biden administration pulled the plug on a Trump-era State Department investigation into whether COVID-19 originated from the Wuhan Institute of Virology in China, according to a Tuesday evening report by CNN.

The effort, led by then-Secretary of State Mike Pompeo, also sought to determine whether China’s biological weapons program may have played a role in the pandemic. According to the report, it was met with internal opposition from officials who thought it was simply a politicized witch hunt to blame China for the virus.

According to three unnamed sources, when Biden was briefed on the investigations’ findings in February and March, he pulled the plug – and instead opted to trust the findings of the World Health Organization, which conducted an ‘investigation’ earlier this year which turned out to be nothing more than political theater, the cast of which included the highly conflicted Peter Daszak, the Fauci-funded virologist who was studying bat viruses at the Wuhan lab.

“The way they did their work was suspicious as hell,” said one former State Department official who (we’re guessing was rooting for team Schiff during Trump’s impeachment).

Pompeo, meanwhile, said in May 2020 that there was “enormous evidence” and a “significant amount of evidence” to support the lab-escape theory. And according to former senior State Department official David Feith, “People in the US government were working on the question of where Covid-19 came from but there was no other effort that we knew of that took the lab leak possibility seriously enough to focus on digging into certain aspects, questions and uncertainties.

The revelation that Biden shut down the inquiry is awkward at best, after the Wall Street Journal reported on Sunday that three researchers at the Wuhan Institute of Virology were so sick in November of 2019 that they sought hospitalization, citing the intelligence report that Biden rejected.

The details of the reporting go beyond a State Department fact sheet, issued during the final days of the Trump administration, which said that several researchers at the lab, a center for the study of coronaviruses and other pathogens, became sick in autumn 2019 “with symptoms consistent with both Covid-19 and common seasonal illness.

The disclosure of the number of researchers, the timing of their illnesses and their hospital visits come on the eve of a meeting of the World Health Organization’s decision-making body, which is expected to discuss the next phase of an investigation into Covid-19’s origins. -WSJ

The lab leak theory, floated by Zero Hedge and several other outlets in early 2020, was promoted heavily by former President Trump, who blamed China for unleashing the virus on the world and derailing historic economic growth following three years of ‘America First’ international negotiations, along with generous tax breaks.

“I said it right at the beginning, and that’s where it came from,” Trump told Newsmax Tuesday night, taking somewhat of a victory lab over the MSM’s ‘come to Jesus’ moment over the mounting lab leak hypothesis. “I think it was obvious to smart people. That’s where it came from. I have no doubt about it. I had no doubt about it. I was criticized by the press.”

Trump also said he remains confident that the lab leak theory is correct.

“‘People didn’t want to say China. Usually they blame it on Russia,” he continued. “I said right at the beginning it came out of Wuhan. And that’s where all the deaths were also, by the way, when we first heard about this, there were body bags, dead people laying all over Wuhan province, and that’s where it happened to be located.”

To me it was very obvious. I said it very strongly and I was criticized and now people are agreeing with me, so that’s okay.

 

Tyler Durden
Wed, 05/26/2021 – 08:05

via ZeroHedge News https://ift.tt/3ulg69K Tyler Durden

Futures Jump As Coordinated Central Bankers Push Back On Inflation Fears

Futures Jump As Coordinated Central Bankers Push Back On Inflation Fears

US equity futures rose on Wednesday, rebounding from a modest dip  the day before as more central-bank officials joined the chorus predicting that inflationary pressures are transitory, while a recent dip in bond yields supported Nasdaq futures climb for a third straight session. At 7:15 a.m. ET, Dow e-minis were up 82 points, or 0.24%, S&P 500 e-minis were up 14 points, or 0.33%, and Nasdaq 100 e-minis were up 51.25 points, or 0.38%. Treasuries and the dollar were roughly flat, recovering from an earlier drop. BItcoin soared back over $40,000, rising as much as 8.6%, before paring gains.

Among the notable premarket moves were retail trader favorites GameStop and AMC which surged in U.S. premarket trading, adding to Tuesday’s rally as investors touted the stocks on social media platforms including Twitter, Stocktwits and trader WallStreetBets. The gains will add to losses for short-sellers of the stocks who have already seen $6.8 billion in mark-to-market losses this year, according to S3 Partners. GameStop climbed 4.3% to $218.40, while AMC added 3.8% to $17.04 at 7:10am in New York.

Here are some other notable premarket movers:

  • Larimar Therapeutics slumps in premarket trading after the U.S. Food and Drug Administration placed a clinical hold on its CTI-1601 drug.
  • Nabriva Therapeutics jumps after the company, alongside Sinovant Sciences, said Tuesday that lefamulin was shown to be non-inferior to moxifloxacin.
  • Urban Outfitters jumped 9.3% after reporting 1Q results after market Tuesday that beat profit and sales estimates. Analysts see the apparel maker as a retail recovery play, with Jefferies saying the strong results will “bring bulls back,” while JPMorgan upgraded the retailer to neutral from underweight.
  • Oil heavyweight Exxon Mobil Corp gained 0.7% ahead of its first major boardroom contest where climate change is a central issue.
  • Crypto- exposed stocks like Riot Blockchain, Marathon Patent Group and Coinbase Global rose between 2% and 4.6% in premarket trading as bitcoin climbed back above $40,000 for the first time this week with other cryptocurrencies recovering some of the ground lost this month.
  • Nordstrom dropped 6% in thin trading after reporting a bigger-than-expected quarterly loss, hurt by price markdowns.

Futures rose after a downbeat Tuesday, where the S&P closed down 8 points, despite Fed vice chair Richard Clarida downplaying the effects of higher price pressures, voicing faith in the central bank’s ability to engineer a “soft landing” if prices continue to escalate beyond what is expected. All the same, Clarida’s comments reflect a shifting tone at the Fed. A month ago, Fed Chair Jerome Powell said it was “not yet” time to even contemplate discussion of policy tapering, but more recently policymakers have acknowledged they are closer to debating when to pull back some of their crisis support for the U.S. economy. This is why, as we noted overnight, the narrative on Wall Street is starting to shift, portraying the taper as a positive or bullish catalyst.

“The messages were not necessarily new but they reinforced the prevailing consensus still that the bulk of the surprise in April (CPI) can be traced to transitory elements,” said Stefan Hofer, chief investment strategist at LGT in Hong Kong. “The proof is in the pudding so to speak over the coming months, how much of the CPI increase is structural and how much of it is transitory. And the jury is I would say still out on that, but the Fed is sticking to its guns and markets seem to be by and large still comfortable with that.”

Fears of soaring inflation have weighed on Wall Street’s main indexes this month, with most analysts expecting a jump in borrowing costs in the short term as the economy reopens, even though a recent Chinese crackdown on commodity prices coupled with a plunge in China’s credit impulse suggests a deflationary wave is coming. Furthermore, central bankers around the globe are playing down the risk of rising prices. The question, as Bloomberg notes, is how long the Fed and other central banks can keep stimulative monetary policy in place if economic data continue to show price pressures.

“What we keep hearing from the Fed is that they’re going to take a very different approach to inflation this time around,” Kristina Hooper, Invesco chief global market strategist, said on Bloomberg TV. “The Fed is likely to let the punchbowl stay out a lot longer. The big fear about inflation is that the Fed would act.”

Europe’s Stoxx 600 Index erased earlier gains of as much as 0.4% as the rally lost steam after the region’s stocks approached record levels. Banks pulled the index lower with the banks subgroup index down 1.5%, after a report on Sweden’s lenders facing new tax. The travel & leisure subgroup index trim gains to 0.9%. Here are some of the biggest European movers today:

  • Marks & Spencer shares rose as much as 6.3% to highest intraday since March 2020. The U.K. retailer’s FY results showed continued improvement in its balance sheet as well as “constructive” comments for the year ahead, according to Morgan Stanley.
  • Softcat shares jumped as much as 6%, the most since March 24, after the IT services firm says it sees its full-year earnings ahead of expectations.
  • Norwegian Air shares rose as much as 31% as a restructuring proposal is expected to take effect after close of trading on the Oslo Stock Exchange on May 26.
  • Vectura Group shares gained as much as 34% to a price above the level of an agreed offer from Carlyle Group that values the U.K. drug maker at GBP958m. Stifel said the offer represents a fair premium to their price target.
  • Solutions 30 shares jumped as much as 26%, rebounding from a slump in the previous two sessions, after CEO Gianbeppi Fortis sought to reassure investors worried about pressures from short sellers and its auditor’s decision not to certify the company’s 2020 accounts.
  • Spire Healthcare shares rose as much as 29% after agreeing to a takeover by Ramsay Health Care. RBC said “it may not have taken much for Spire’s share price to reach this” without a bid, “given the pent-up demand in the market”
  • De La Rue shares fell as much as 8.3% before trimming the decline after the banknote and authentication document-maker’s full-year results. Company has been speculated upon as a potential producer of Covid-19 “vaccine passports.”

Similar to Clarida, Bank of France Governor Francois Villeroy de Galhau talked down stimulus adjustments anytime soon, while European Central Bank Executive Board member Fabio Panetta said he sees no signs of sustained inflation that would allow for a reduction in bond purchases.

In Asia, stocks rose for a fifth day as the soothing Fed comments helped boost sentiment with MSCI’s broadest index of Asia-Pacific shares outside Japan rising 0.28% near more than two-week highs, while Tokyo’s Nikkei added 0.27%. The MSCI Asia Pacific Index climbed above its 50-day moving average on Wednesday, a sign that the region’s stocks have steadily recovered from a slump in early May.

“The weaker U.S. dollar has helped non-USD assets,” said Linus Yip, a strategist at First Shanghai Securities in Hong Kong. However, the sustainability of market gains remains uncertain as “we haven’t seen a significant change in Asia economies. And the pandemic hasn’t been controlled in India and Taiwan,” he said. The Bloomberg Dollar Spot Index fell as much as 0.2% in its third day of declines before paring some losses. The gauge is hovering near its year-to-date low. A weaker greenback tends to be beneficial for Asian shares if it signals higher risk appetite and is seen as a positive for growth in the region’s emerging economies, many of which rely on imports priced in dollars. Stocks in India were on track for a record close. Chinese equities ended little changed after the CSI 300 Index jumped 3.2% on Tuesday, the most since July. Hong Kong stocks rose to the highest level in almost a month. Communication services and industrial shares led the gains in Asia, while materials stocks posted declines. China’s internet giant Tencent and Taiwan’s TSMC contributed the most to the regional benchmark’s advance. Markets in Singapore, Indonesia, Thailand and Malaysia were shut for holidays.

Japanese equities overcame early turbulence to post their fifth-straight day of gains, as investors were encouraged by signs of calm in external financial markets. Electronics makers were the biggest boost to the Topix, which has eked out a gain of 1.3% over the past five sessions, helped also by optimism over a ramp-up of Japan’s coronavirus vaccination program. Fast Retailing and Recruit contributed most to gains in the Nikkei 225. A measure of volatility on the blue-chip gauge fell to its lowest since May 10. Stocks fluctuated in early Tokyo trading after U.S. shares fell overnight. “U.S. long-term yields have retreated quite a bit, and that is probably quite a big factor leading to the calm in markets,” along with smaller moves in Bitcoin, said Ayako Sera, a market strategist at Sumitomo Mitsui Trust Bank. “We have U.S. jobs data coming up next week, but for now, we’re in an environment that’s extremely good for equity markets, with U.S. economic conditions being good while inflation is contained.”

Analysts at Jefferies said Asian regional equity markets could benefit, especially given a weak dollar could help boost global trade and emerging markets by lowering global prices of goods and services. “A weak dollar should underwrite emerging market performance despite very mixed vaccine roll-outs to date,” they said in a note. “Until the U.S. government declares the pandemic is over and job growth is running at one million plus per month, tapering is unlikely to happen…In the meantime, real rates will be heavily negative. Moreover, based on the dollar’s Real Effective Exchange Rate, the greenback cannot be described as being ‘cheap’.”

In rates, Treasuries little changed across the curve after paring losses amid bund rally. US Treasuries fell to multi-week lows on Tuesday on easing inflation concerns and a strong auction of 2-year notes. The yield on the benchmark 10-year Treasury note stood at 1.5638 after scaling a more than one-month high earlier in May. Higher yields pressured valuations for tech and other growth stocks, whose future cash flows are discounted at higher rates after the ECB’s Panetta said only sustained inflation could warrant slowing PEPP. European price action dominated the rates market, with German 10-year almost 4bp richer vs U.S. as markets pare taper expectations. Treasury auction cycle continues with 5-year note sale, following strong demand for Tuesday’s 2-year.

In FX, the Bloomberg Dollar Spot Index fell a third day and the greenback traded mixed versus its Group-of-10 peers, with Antipodean currencies leading gains; The euro fluctuated at around $1.2250; the euro erased a modest gain at the beginning of the European session, and the region’s government bonds advanced, as ECB Executive Board member Fabio Panetta said he sees no signs of sustained inflation pressures that would allow for a reduction in bond purchases yet. On the other end of the spectrum, New Zealand’s dollar led G-10 gains to touch a three-month high and swap rates surged after RBNZ published official cash rate forecasts for the first time in more than a year that show the rate beginning to rise in mid-2022.

The onshore yuan rose for a fourth day to its highest in three years after the PBOC set the yuan’s daily midpoint fixing at its strongest level since June 2018, signaling its comfort with a recent rally after the currency tested a key level against the dollar a day earlier, prompting state banks to step into curb the rally.

In commodities, oil was little changed as traders weighed expectations of improving demand in the U.S. against the possibility of new supply from Iran. Global benchmark Brent crude was up 3 cents at $68.68 and U.S. crude fell 7 cents to $66 per barrel. Bitcoin traded around $40,000, earlier crossing above the key barrier, despite China’s northern region of Inner Mongolia escalating a campaign against cryptocurrency mining on Tuesday, days after Beijing vowed to crack down on bitcoin mining and trading. Gold extended its advance after Federal Reserve official Clarida talked down prospects for inflation, piling pressure on Treasury yields.

It’s a fairly quiet day ahead now on the calendar, with the data highlights including French consumer confidence for May, and central bank speakers including Fed Vice Chair Quarles and the ECB’s Villeroy. Earnings releases include Nvidia, and the CEOs of a number of Wall Street firms will be testifying before the Senate Banking Committee.

Market Snapshot

  • S&P 500 futures up 0.3% to 4,197.50
  • STOXX Europe 600 rose 0.23% to 446.25
  • MXAP up 0.3% to 207.32
  • MXAPJ up 0.4% to 695.72
  • Nikkei up 0.3% to 28,642.19
  • Topix little changed at 1,920.67
  • Hang Seng Index up 0.9% to 29,166.01
  • Shanghai Composite up 0.3% to 3,593.36
  • Sensex up 0.6% to 50,965.37
  • Australia S&P/ASX 200 down 0.3% to 7,092.53
  • Kospi little changed at 3,168.43
  • Brent Futures up 0.2% to $68.78/bbl
  • Gold spot up 0.5% to $1,907.81
  • U.S. Dollar Index little changed at 89.73
  • German 10Y yield fell 2.2 bps to -0.189%
  • Euro little changed at $1.2245

Top Overnight News from Bloomberg

  • U.S. three-month 10-year implied swaption volatility — a closely watched gauge of how much prices may move over the period — has been steadily declining, and hit the lowest levels since early March, as officials repeat the line that inflation will be transitory
  • Bitcoin rallied back above the $40,000 level as cryptocurrencies recover some of the ground lost in this month’s volatile rout. Bitcoin’s explosive moves are stoking the volatility of U.S. stock futures in haywire trading days, according to Singapore’s DBS Group Holdings Ltd
  • The U.K. government was forced to backtrack over its attempt to restrict travel to coronavirus hotspots in England where the so-called Indian variant is spreading. The U-turn came after ministers were accused of introducing “local lockdowns by the back door” with the new guidance against travel to eight areas in England, which was published without fanfare online late last week but didn’t reach the attention of local leaders for several days
  • China’s banking regulator has asked lenders to stop selling investment products linked to commodities futures to retail buyers, Reuters reports, citing three unidentified people
  • Europe’s labor market may recover more slowly from the pandemic than its economy, according to a study by Accenture. The region lost 3.5 million jobs in 2020 that will take until 2023 to be recreated, the consultancy said, citing a survey of 700 company executives. That’s as much as one year after the last European Union economy will have seen output returning to pre-crisis levels

A quick look at global markets courtesy of Newsquawk

Asia-Pac stocks were mostly positive in what was a modest improvement from the subdued performance on Wall Street where most major indices posted marginal losses following mixed data releases, although the Nasdaq 100 bucked the trend amid resilience in tech and as softer yields helped stem downside in duration sensitive stocks. ASX 200 (-0.3%) was kept afloat for most of the session amid notable strength in tech and outperformance in gold miners after the precious metal reclaimed the USD 1900/oz level. Furthermore, the top-weighted financials were also higher as shares in big-4 leader CBA briefly topped AUD 100 for the first time, although gains in the broader marker were limited amid snap lockdown concerns in Victoria state which reported 10 new locally transmitted cases and after a COVID-positive person was confirmed to have attended a match at the Melbourne Cricket Ground. Nikkei 225 (+0.9%) traded positively amid reports that Japan’s government is considering another cash handout program of up to JPY 100k for households in need, but with upside restricted amid expectations of state of emergency extensions and further calls for the cancellation of the Olympics, this time coming from an editorial by Asahi Shimbun press, which is an official partner of the Tokyo Olympics. Hang Seng (+0.6%) and Shanghai Comp. (+0.3%) held on to the spoils from the prior day’s outperformance where northbound flows into the Chinese mainland through the stock connect reached record levels. Focus was also on Xiaomi after it received the final US District Court ruling which removed its designation as a Communist Chinese Military Company and lifted all restrictions on the Co.’s shares, although this failed to boost its share price with participants awaiting its earnings results. Finally, 10yr JGBs were rangebound with upside restricted amid the mild positive risk tone and with the BoJ only in the market for treasury bills, while New Zealand 10yr yields gained around 8bps following the RBNZ rate hike projections.

Top Asian News

  • Two Million Evacuated as Cyclone Hits India Amid Virus Woes
  • Japan Ministry Says UBS No Longer Primary Dealer for JGBs
  • Nine-Day Wait for Covid Test Results Leaves Taiwan in Limbo
  • Triumphant Assad Eyes Return to Arab Fold as Syrians Vote

Major bourses in Europe kicked off the day with mild gains but have since drifted off best levels (Euro Stoxx 50 -0.2%) with the region now seeing a mild downside bias amid a light European morning in terms of data and news flow, and as month-end looms. US equity futures meanwhile hold onto modest gains, but the breadth of the price action remains narrow with no clear stand-out performers. Analysts at Barclays note that fatigue and inflation woes have seen investors trimming bullish bets over the last month. “Cyclical exposure has moderated, but Value has recovered its 2020 outflows, with buying of Financials, Energy and Materials outpacing Tech. Value is thus more consensus and prone to profit-taking but can still benefit from higher rates and momentum rebalancing, in our view.”, the bank says. Barclays also suggests that the correlations between the broader equity market vs cryptos and SPACs have been relatively lower, meaning little contagion in the bank’s view. “Overall, less complacency reduces correction risk, and investors have dry powder to keep buying on dips, which should support a further grind higher in equities.”, the analysts note. Back to Europe, cash bourses are trading either side of neutral while sectors have been tilting more towards a defensive bias as Personal Household Goods, Food & Beverages and Healthcare reside among the better performers. Travel & Leisure is the clear outperformer as sector heavyweight Flutter Entertainment (+2%) is underpinned by an upgrade at HSBC – note, Flutter accounts for over 1/5th of the sector. Banks and Basic resources meanwhile reside at the bottom of the pile amid the recent pullback in yields and as some base metal prices in Asia slumped. Tech also resides as laggards following its recent outperformance. In terms of individual movers, Marks & Spencer (+4.8%) is among the top gainers post-earnings as the group notes that its balance sheet has emerged stronger than expected and online sales doubled in the period. Meanwhile, Spire Healthcare (+24%) was bolstered as Ramsay Healthcare offered to purchase 100% of Spire for GBP 2.40/shr in a deal valued at around GBP 2bln. On the downside, Nordea (-0.6%) sees losses as its largest shareholder Sampo (-1.0%) offloaded 162mln shares to institutional investors.

Top European News

  • U.K. Could Block Some London Listings on Security Grounds
  • Ireland Needs Credible Fiscal Strategy, Watchdog Warns
  • Czech Central Bank Is Deciding Between June and August Rate Hike
  • Swedish Banks Face New Tax to Cover ‘Enormous’ Crisis Costs

In FX, the Kiwi was already taxiing in preparation for the RBNZ policy meeting, but took off in wake of the Bank signalling lift-off for the OCR at the end of Q3 next year and flagging the end of the LSAP remit by June 2022. Indeed, Nzd/Usd scaled the 0.7300 handle and Aud/Nzd cross retreated through 1.0650 even though the Aussie is holding gains vs the Greenback following firmer than forecast Q1 construction work completed that offset a dip in Westpac’s leading index for April. However, Aud/Usd ran into resistance just ahead of 0.7800 and will now be looking towards Q1 Capex and the breakdown for further impetus, while observing decent option expiry interest for the NY cut in the interim given 1.2 bn rolling off between 0.7750-40 and 1.1 bn from 0.7770-85.

  • USD/GBP/CHF/CAD/EUR/JPY – There may be an element of intraday or short term jobbing rather than strictly technical impulses behind the latest Buck bounce as the DXY managed to hold above 89.500 again and pare losses off a slightly higher low compared to Tuesday, but other factors have contributed, including the latest dovish interjection from the ECB. Indeed, GC member Panetta went further than his peers in a speech containing rationale for delaying any decision about unwinding the pace of QE in Q3 when he noted a non-negligible appreciation of the Euro exchange rate to knock the single currency back down below 1.2250. Predictably, the ensuing Dollar rebound that lifted the index to 89.794 at one stage, rippled across to the remaining basket constituents, with Cable off peaks circa 1.4172, Usd/Chf firmer around a 0.8950 axis post-more dovish remarks from SNB head Jordan, Usd/Cad towards the upper end of a 1.2043-82 range and Usd/Jpy in the high 108.00 area again as the Japanese Government downgrades its official view of the economy amidst further contagion from COVID-19.
  • SCANDI/EM/PM – Some payback for the Sek vs the Nok and Eur after an uptick in Sweden’s sa jobless rate and the Riksbank’s latest FSR revealing a brighter outlook, but risks to stability still deemed to be elevated. Conversely, the Nok may be deriving some underlying support from a mild bid in Brent and Q2 Norwegian oil investment forecasts showing increases in the current year and 2022, while the Cnh and Cny are going from strength to strength, partly on the back of a higher onshore fixing from the PBoC overnight (in fact the loftiest midpoint in almost 3 years) and the CSJ highlighting analyst predictions for more Yuan upside based on Usd weakness, China’s trade surplus and economic recovery. Elsewhere, the Try has regained a bit of composure after sliding to a fresh all time low near 8.4850 on Tuesday and the Zar continues to glow in the shadow of Gold that has topped Usd 1900/oz.
  • RBNZ maintained policy settings as expected with the OCR kept at 0.25% and both LSAP and Funding for Lending Programme were also left unchanged, although it provided rate forecasts which pointed to a 25bps hike in September 2022 and to 1.75% by June 2024. RBNZ stated that it will maintain stimulatory monetary settings until it is confident inflation and employment targets are achieved, while it added that domestic economic activity has returned to near pre-pandemic levels and that the medium-term outlook is similar to scenario presented in February, but they remain cautious due to ongoing virus-related restrictions to activity. In terms of forecasts, the RBNZ sees the OCR at 0.25% in September 2021, 0.31% in June 2022, 0.49% in September 2022 and 1.78% in June 2024, while Governor Orr stated at the press conference that he feels comfortable using the OCR projection as a guidance but noted that the projection will only occur if the economy pans out as expected and Deputy Governor Hawkesby also suggested the important message is that OCR is not forward guidance. (Newswires)

In commodities, WTI and Brent front month futures have been choppy within relatively narrow bands with the former on either side of USD 66/bbl (65.81-66.43 range) and the latter around USD 69/bbl (68.44-69.17 range). Crude markets have been somewhat uneventful throughout the European morning after a relatively mixed Private Inventory report (Crude -0.44mln vs exp. -1.1mln), and ahead of the DoEs where the headline is forecast to draw 1.05mln bbls. Elsewhere, eyes remain on Iranian nuclear talks with the Iranian president recently noting that a common understanding has been found on some key points, but the US must take the first step – several officials hope for this to be the final round of talks. On this, Russian Deputy PM Novak hit the wires ahead of the June 1st JMMC/OPEC+ meeting, stating that the group will have to keep Iranian output growth in mind. Iran is currently exempt from the OPEC+ quotas amid US sanctions. Elsewhere, spot gold and silver remain buoyed by the recent Dollar, and yield declines. Spot gold reclaimed USD 1,900/oz status overnight (vs low 1,897/oz) before encountering a barrier at USD 1,910/oz in early European hours. Spot silver meanwhile surpassed USD 28/oz. Over to base metals, LME copper trades on a firmer footing and eclipsed USD 10,000/t to the upside, underpinned by reports that unions at BHP’s Escondida mine rejected the labour offer, thus paving the way for strikes. The Escondida copper mine is currently the world’s largest copper mine by reserve. Overnight, steel rebar futures in Shanghai extended on losses, whilst Singapore and Dalian iron ore futures fell over 5% apiece after China’s NDRC held a meeting with key enterprises in the steel industry.

US Event Calendar

  • 7am: May MBA Mortgage Applications, prior 1.2%
  • 10am: Fed’s Quarles Discusses Insurance Regulation
  • 3pm: Fed’s Quarles Discusses the Economic Outlook

DB’s Jim Reid concludes the overnight wrap

It’s fair to say that we’re in a holding pattern for now. The inflationists have undoubtedly won the first round of the data war but central banks, and in particular the Fed, have won the early PR skirmishes. To expand on this you only have to see my CoTD yesterday (link here) to appreciate that US inflation surprises are almost off the charts and higher than ever before. Whether or not it’s transitory, economists have completely underestimated its strength so far. Markets though have for now preferred to be calmed by what has been a seemingly coordinated dovish response from the Fed. Their messaging has been excellent for calming markets. If inflation is transitory they have done a phenomenally good job. However here’s where round 2 will get interesting. If it isn’t transitory they have really boxed themselves in and they’ll need to make a disruptive big step change to the messaging. So an awful lot is at stake here.

This bigger theme played out on a very small scale yesterday as investors weighed up competing pressures to the economic outlook. On the one hand, weaker-than-expected economic data served to dampen sentiment following a recent run of very strong growth. But on the other, the reports raised the prospect that inflationary pressures were more likely to be subdued, helping to reduce a key concern of investors lately, whilst also raising the likelihood that monetary stimulus from the Fed would be maintained for longer. By the close of trade the negatives had marginally outweighed the positives, in turn sending the S&P 500 down to a small -0.21% loss, with the Dow Jones (-0.24%) and the NASDAQ (-0.03%) also experiencing modest declines.

Nearly 75% of all S&P 500 members saw their shares decline though in a broad selloff that was particularly hard on cyclical industries that have outperformed this year. Energy (-2.04%), Banks (-1.18%) and Material (-0.88%) stocks were among the worst performers as commodity prices and yields declined. European equities saw a similar dynamic with Basic resources (-1.73%) and Energy (-1.43%) shares the largest laggards as Technology (+1.29%) caught up to the US tech rally the day earlier after German markets came back from their Monday holiday. The STOXX 600 overall was basically unchanged (+0.03%) after registering its smallest daily move in nearly a month.

In terms of those releases, there were a number of data points that surprised to the downside out of the US. Firstly, the Conference Board’s consumer confidence index for May fell to 117.2 (vs. 118.8 expected), marking the first decline in the measure this calendar year. Furthermore, the previous month’s figure was revised down -4.2 points to 117.5, so a slightly less rosy picture of what went before, whilst the expectations gauge hit a 3-month low of 99.1. Separately, new home sales fell to an annualised rate of 863k (vs. 950k expected) amidst a big surge in prices, with the prior month similarly revised down -104k to 917k. And speaking of that price surge in housing, the Case-Shiller 20-city composite city home price index was up +13.3% year-on-year, the fastest annual increase since December 2013.

These data points were supplemented by comments from Fed Vice Chair Clarida reiterating much of what was said in last week’s release of the April Fed meeting minutes. He said that it’s possible that “in upcoming meetings, we’ll be at the point where we can begin to discuss scaling back the pace of asset purchases.” Clarida believes that pricing pressures will eventually “prove to be largely transitory”. The Vice Chair also noted that the macro data is likely to continue to be volatile, citing the most recent employment report, which “really highlights a fair amount of near-term uncertainty about the labor market.”

Though equities struggled for traction given the data, the reports were much better news for sovereign bond markets, which gained further ground as investors again moved to downgrade the pace of rate hikes over the next couple of years. Yields on 10yr US Treasuries fell -4.2bps to 1.559% in their 4th consecutive move lower, which is the benchmark’s lowest closing levels since April 23. European countries saw an even larger decline in yields, with those on 10yr bunds (-2.7bps), OATs (-3.8bps) and gilts (-2.5bps) all falling back. Once again, Greek debt was a relative outperformer, with the spread of their 10-year yields over bunds falling to a 12-year low of 1.07%.

Overnight in Asia, equities have posted gains for the most part, with the Nikkei (+0.29%), the Shanghai Comp (+0.29%) and the Hang Seng (+0.76%) all advancing. The exception to this pattern is the Kospi however, which has fallen -0.22%. Elsewhere, the New Zealand dollar surged against other major currencies (+1.12% vs USD) after the RBNZ brought back their projection of the Official Cash Rate, which pointed to a rate hike in the second half of 2022. In turn, this also led to a surge in yields, with those on the country’s 10yr debt seeing a +8.2bps increase this morning. US equity futures are pointing higher this morning, with those on the S&P up +0.29%.

Back to yesterday, and on the political front we got confirmation from the White House that President Biden would be meeting Russian President Putin in Geneva on June 16. This is their first in-person meeting since Biden’s inauguration and comes amidst tensions between the two sides over a range of issues, with the US having recently imposed fresh sanctions on Russian officials over the poisoning of Alexei Navalny. The meeting between the two will come directly after Biden’s attendance at the G7 summit in the UK from June 11-13, followed by a meeting of the NATO heads of State and Government in Brussels on June 14.

Staying on the political sphere, today also marks exactly 4 months until the German election in September, and the polls have recently begun to indicate that the Green Party’s surge in the polls has shown signs of stalling. That big increase followed the selection of Annalena Baerbock as the party’s chancellor candidate, but her popularity has shown signs of ebbing, which is probably to do with news stories from last week that she failed to report bonus payments that she’d received from her party. This isn’t necessarily a turning point, and the overall polling average from Bloomberg still puts the Greens on 23.6%, which is just shy of the CDU/CSU bloc on 24.4%. But that’s still a reversal from just 3 weeks earlier, when the same average put the Greens ahead on 24.8%, compared to the CDU/CSU’s 24.1%. As a reminder, our German economists’ baseline call is that there’ll be a CDU/CSU-Green government.

On the pandemic, we got the news yesterday that the Moderna vaccine was between 93% and 100% effective at preventing symptomatic Covid among 12-17 year olds, depending on whether you included very mild cases. In turn, this opens the prospect that the vaccine will soon join the Pfizer vaccine in being cleared by the US for younger age groups. Separately, the White House has announced that half of all American adults are now fully vaccinated. Elsewhere, the UK government also issued some revisions to their own guidance for 8 council areas where the Indian variant is spreading the fastest. They’re recommending that people should meet outside rather than inside where possible, and avoid travelling into or out of those areas unless essential. The new advice was actually published online on Friday, but was done without an announcement and only came to the attention of the wider media over the last couple of days. France is considering imposing travel restrictions on those coming and going to Britain following reports of the Indian variant. Elsewhere parts of Southeast Asia continue to struggle under the current wave of infections with Malaysia now seeing more per capita daily cases than India.

Looking at yesterday’s data, the Ifo’s business climate indicator from Germany for May rose to 99.2 (vs. 98.0 expected), which is its strongest level in 2 years. The expectations (102.9) hit its highest since April 2017, while the current assessment reading (95.7) reached its highest since February 2020.

It’s a fairly quiet day ahead now on the calendar, with the data highlights including French consumer confidence for May, and central bank speakers including Fed Vice Chair Quarles and the ECB’s Villeroy. Earnings releases include Nvidia, and the CEOs of a number of Wall Street firms will be testifying before the Senate Banking Committee.

Tyler Durden
Wed, 05/26/2021 – 07:52

via ZeroHedge News https://ift.tt/2SybZtO Tyler Durden

Medicare for All Is Bad Medicine


dreamstime_m_211917905

Opponents of choice in medicine are at it again, promoting Medicare for All with the U.S. government as the single payer and private alternatives outlawed. The push comes as health care systems around the world try to catch their breath from the stress test inflicted by the pandemic—and by normal demand for expensive services. While American medicine has its share of problems, single-payer supporters would take all of the flaws in the system and make them universal and mandatory.

“Everybody in! Nobody out!” protesters chanted in Toledo, Ohio, this week in an attempt to pressure Rep. Marcy Kaptur (D-Ohio) to sign on to H.R.1976, the Medicare for All Act of 2021. They should have added “or else,” since the bill, with 115 cosponsors at the moment, makes it “unlawful for … a private health insurer to sell health insurance coverage that duplicates the benefits provided under this Act” or for employers to offer alternative coverage.

Providers wouldn’t be forced to participate; the proposed law lets Americans pay non-participating physicians out of pocket for services—subject to regulations. Why would Americans pay for services covered by a hypothetical Medicare for All? To answer that question, look north of the border, where Canada’s single-payer system, commonly called Medicare, struggles to meet patients’ needs.

“With COVID-19 fuelling a surge in hospitalizations, the latest data provided by the Ministry of Health shows that as of December 31, 2020, there were 29,650 people on a waiting list for surgery” in Saskatchewan, the Canadian Broadcasting Corporation (CBC) reported earlier this month. The CBC noted similar delays in other provinces.

“Specialist physicians surveyed report a median waiting time of 22.6 weeks between referral from a general practitioner and receipt of treatment,” which is the longest wait recorded, according to the free-market Fraser Institute.

As of 2020 only 62 percent of Canadians told Commonwealth Fund pollsters that they “waited less than 4 months for non-emergency or elective surgery after they were advised they needed it,” compared to 92 percent of Americans. Only 38 percent of Canadians were able to see a specialist (who might recommend such surgery) within four weeks, compared to 69 percent of Americans.

Such waits cost more than money—although they cost plenty of that. “[T]wice as many Ontarians with heart ailments passed away waiting for surgery during the pandemic than before COVID-19 hit,” according to the National Post.

To relieve the backlog, Canadian provincial governments, which manage the single-payer system, are turning to private clinics. In Quebec, “without the private sector contracts, a region like Laval would have delayed 76 per cent of surgeries instead of 31 per cent,” the CBC noted in February.

As the data suggests, though, the public sector in many places had trouble delivering as advertised long before anybody had heard of COVID-19. In Germany, where those making less than €64,350 per year must participate in the government health insurance system which is funded on a quarterly basis, the system runs out of money on a regular basis.  

“State health insurance patients are struggling to see their doctors towards the end of every quarter, while privately insured patients get easy access,” Deutsche Welle reported in 2018. “The researchers traced the phenomenon to Germany’s ‘budget’ system, which means that state health insurance companies only reimburse the full cost of certain treatments up to a particular number of patients or a particular monetary value … Once that budget has been exhausted for the quarter, doctors slow down — and sometimes even shut their practices altogether.”

The “budget” acts as backdoor rationing, limiting costs by choking off access for publicly insured patients to all but emergency medical care once the magic number is hit. Single-payer advocates often criticize private medicine for being cost-conscious, but government systems put at least as much emphasis on the bottom line as any corporate accountant.

That’s especially obvious in the United Kingdom, where the National Health Service has a cult-like status. During the pandemic, this took the form of a “Stay Home. Protect the NHS. Save Lives.” campaign. “The NHS is under severe strain and we must take action to protect it, both so our doctors and nurses can continue to save lives and so they can vaccinate as many people as possible as quickly as we can,” Prime Minister Boris Johnson scolded the public

The campaign worked. Even people with medical concerns stayed home, resulting in a drop in doctor visits and a 90 percent plunge in hospital admissions.

“We are sadly seeing the fallout of people not getting cardiovascular care during this pandemic – with thousands of excess deaths caused by these conditions,” Dr. Sonya Babu-Narayan, the associate medical director at the British Heart Foundation, told The Telegraph in October 2020.

Even that wasn’t enough. Britons staying at home were advised to refrain from home repairs and gardening that might result in injuries burdensome to the government-run health care system.

“It suggests our treatment of the NHS as a religion has reached such a dizzying level that the government thinks the best way to secure our obedience during this lockdown is by telling us we’ll be helping to Save the NHS,” objected Brendan O’Neill in The Spectator.

It’s difficult to imagine Americans venerating government bureaucracy (although feelings about Social Security come disturbingly close). But it’s impossible to pretend that Medicare for All could escape the concerns that plague all tax-paid medicine. “A doubling of all currently projected federal individual and corporate income tax collections would be insufficient to finance the added federal costs of the plan,” the Mercatus Center’s Charles Blahous pointed out about an earlier Medicare for All proposal.

That’s not to say that American medicine couldn’t be improved; it suffers from cost and access problems of its own. Much of the problem comes from previous government interference in what is no longer even close to being a free market. Under the Affordable Care Act, federal regulators deliberately pushed previously independent physicians and small clinics to consolidate out of a smug belief that the health care industry would operate better in the hands of fewer operators. 

Those remaining operators are heavily regulated, and at great expense. “Providers are dedicating approximately $39 billion per year to comply with the administrative aspects of regulatory compliance,” warned a 2017 American Hospital Association report.

Health care in the United States requires reform, without doubt. But rather than emulate the heavy state involvement that evokes headaches elsewhere in the world, a better prescription would be to get government entirely out of medicine and encourage more competition and choice.

from Latest – Reason.com https://ift.tt/3fNNZuq
via IFTTT

Medicare for All Is Bad Medicine


dreamstime_m_211917905

Opponents of choice in medicine are at it again, promoting Medicare for All with the U.S. government as the single payer and private alternatives outlawed. The push comes as health care systems around the world try to catch their breath from the stress test inflicted by the pandemic—and by normal demand for expensive services. While American medicine has its share of problems, single-payer supporters would take all of the flaws in the system and make them universal and mandatory.

“Everybody in! Nobody out!” protesters chanted in Toledo, Ohio, this week in an attempt to pressure Rep. Marcy Kaptur (D-Ohio) to sign on to H.R.1976, the Medicare for All Act of 2021. They should have added “or else,” since the bill, with 115 cosponsors at the moment, makes it “unlawful for … a private health insurer to sell health insurance coverage that duplicates the benefits provided under this Act” or for employers to offer alternative coverage.

Providers wouldn’t be forced to participate; the proposed law lets Americans pay non-participating physicians out of pocket for services—subject to regulations. Why would Americans pay for services covered by a hypothetical Medicare for All? To answer that question, look north of the border, where Canada’s single-payer system, commonly called Medicare, struggles to meet patients’ needs.

“With COVID-19 fuelling a surge in hospitalizations, the latest data provided by the Ministry of Health shows that as of December 31, 2020, there were 29,650 people on a waiting list for surgery” in Saskatchewan, the Canadian Broadcasting Corporation (CBC) reported earlier this month. The CBC noted similar delays in other provinces.

“Specialist physicians surveyed report a median waiting time of 22.6 weeks between referral from a general practitioner and receipt of treatment,” which is the longest wait recorded, according to the free-market Fraser Institute.

As of 2020 only 62 percent of Canadians told Commonwealth Fund pollsters that they “waited less than 4 months for non-emergency or elective surgery after they were advised they needed it,” compared to 92 percent of Americans. Only 38 percent of Canadians were able to see a specialist (who might recommend such surgery) within four weeks, compared to 69 percent of Americans.

Such waits cost more than money—although they cost plenty of that. “[T]wice as many Ontarians with heart ailments passed away waiting for surgery during the pandemic than before COVID-19 hit,” according to the National Post.

To relieve the backlog, Canadian provincial governments, which manage the single-payer system, are turning to private clinics. In Quebec, “without the private sector contracts, a region like Laval would have delayed 76 per cent of surgeries instead of 31 per cent,” the CBC noted in February.

As the data suggests, though, the public sector in many places had trouble delivering as advertised long before anybody had heard of COVID-19. In Germany, where those making less than €64,350 per year must participate in the government health insurance system which is funded on a quarterly basis, the system runs out of money on a regular basis.  

“State health insurance patients are struggling to see their doctors towards the end of every quarter, while privately insured patients get easy access,” Deutsche Welle reported in 2018. “The researchers traced the phenomenon to Germany’s ‘budget’ system, which means that state health insurance companies only reimburse the full cost of certain treatments up to a particular number of patients or a particular monetary value … Once that budget has been exhausted for the quarter, doctors slow down — and sometimes even shut their practices altogether.”

The “budget” acts as backdoor rationing, limiting costs by choking off access for publicly insured patients to all but emergency medical care once the magic number is hit. Single-payer advocates often criticize private medicine for being cost-conscious, but government systems put at least as much emphasis on the bottom line as any corporate accountant.

That’s especially obvious in the United Kingdom, where the National Health Service has a cult-like status. During the pandemic, this took the form of a “Stay Home. Protect the NHS. Save Lives.” campaign. “The NHS is under severe strain and we must take action to protect it, both so our doctors and nurses can continue to save lives and so they can vaccinate as many people as possible as quickly as we can,” Prime Minister Boris Johnson scolded the public

The campaign worked. Even people with medical concerns stayed home, resulting in a drop in doctor visits and a 90 percent plunge in hospital admissions.

“We are sadly seeing the fallout of people not getting cardiovascular care during this pandemic – with thousands of excess deaths caused by these conditions,” Dr. Sonya Babu-Narayan, the associate medical director at the British Heart Foundation, told The Telegraph in October 2020.

Even that wasn’t enough. Britons staying at home were advised to refrain from home repairs and gardening that might result in injuries burdensome to the government-run health care system.

“It suggests our treatment of the NHS as a religion has reached such a dizzying level that the government thinks the best way to secure our obedience during this lockdown is by telling us we’ll be helping to Save the NHS,” objected Brendan O’Neill in The Spectator.

It’s difficult to imagine Americans venerating government bureaucracy (although feelings about Social Security come disturbingly close). But it’s impossible to pretend that Medicare for All could escape the concerns that plague all tax-paid medicine. “A doubling of all currently projected federal individual and corporate income tax collections would be insufficient to finance the added federal costs of the plan,” the Mercatus Center’s Charles Blahous pointed out about an earlier Medicare for All proposal.

That’s not to say that American medicine couldn’t be improved; it suffers from cost and access problems of its own. Much of the problem comes from previous government interference in what is no longer even close to being a free market. Under the Affordable Care Act, federal regulators deliberately pushed previously independent physicians and small clinics to consolidate out of a smug belief that the health care industry would operate better in the hands of fewer operators. 

Those remaining operators are heavily regulated, and at great expense. “Providers are dedicating approximately $39 billion per year to comply with the administrative aspects of regulatory compliance,” warned a 2017 American Hospital Association report.

Health care in the United States requires reform, without doubt. But rather than emulate the heavy state involvement that evokes headaches elsewhere in the world, a better prescription would be to get government entirely out of medicine and encourage more competition and choice.

from Latest – Reason.com https://ift.tt/3fNNZuq
via IFTTT

Inflation, Money, And Supply Bottlenecks

Inflation, Money, And Supply Bottlenecks

Authored by Daniel Lacalle,

“The constant refinancing of debt from companies of doubtful viability also leads to the perpetuation of overcapacity because a key process for economic progress, such as creative destruction, is eliminated or limited”.

One of the arguments most used by central banks regarding the increase in inflation is that it is because of bottlenecks and that the recovery in demand has created tensions in the supply chain. However, the evidence shows us that most commodities have risen in tandem in an environment of a wide level of spare capacity and even overcapacity.

If we analyse the utilization ratio of industrial and manufacturing productive capacity, we see that countries such as Russia (61%) or India (66%) are at a clear level of structural overcapacity and a utilization of productive capacity that remains still several points lower than that of February 2020. In China it is 77%, still far from the 78% pre-pandemic level. In fact, if we analyse the main G20 countries and the largest industrial and commodity suppliers in the world, we see that none of them have levels of utilization of productive capacity higher than 85%. There is ample available capacity all over the world.

Inflation is not a transport chain problem either. The excess capacity in the shipping and transport sector is more than documented and in 2020 new capacity was added in both freights and air transport. Ships delivered in 2020 added 1.2 million twenty-foot equivalent units (TEUs) of capacity, with 569,000 TEUs of capacity on ultra large container vessels (ULCV), ships with capacity for more than 18,000 TEUs, according to Drewry, a shipping consulting firm. International Air Transport Association (IATA) chief economist Brian Pearce also warned that the problem of capacity was increasing in calendar year 2020.

One of the important side effects of the chain of monetary stimuli, low interest rates and fiscal stimulus programs is the increase in the number of zombie companies. The BIS (Bank for International Settlements) has shown this phenomenon in several empirical studies. Ryan Banerjee, senior economist at the BIS, identified the constant policy of lowering rates as a key factor in understanding the exponential increase in zombie companies, those that cannot cover their debt interest bills with operating profits. The constant refinancing of debt from zombie companies also leads to the perpetuation of overcapacity, because a key process for economic progress, such as creative destruction, is eliminated or limited. Low interest rates and high liquidity have perpetuated or increased global installed excess capacity in aluminium, iron ore, oil, natural gas, soybeans and many other commodities.

Why does inflation rise if overcapacity is perpetuated and there is enough transport capacity?

We have forgotten the most important factor, the monetary one, or some central banks want to make us forget it. “Inflation is always and everywhere a monetary phenomenon,” explained Milton Friedman many decades ago. More supply of money directed towards scarce assets, be it real estate or raw materials. The purchasing power of money goes down.

Why did they tell us that there was “no inflation” before COVID-19 if money supply increased also massively?

The big difference between 2020 and the past years is that previously, the Federal Reserve or the ECB increased money supply at or below the levels of demand for money (measured as demand for credit and use of currency). For example, the increase in the money supply of the United States was close to 6% with a global demand for dollars that grew between 7 and 9%. In fact, the world maintains a dollar shortage of about $ 17 trillion, according to Luke Gromen of Forest for the Trees. This keeps the dollar or euro relatively stable and a perception that inflation is low. However, there were red flags before Covid-19. There were protests all over the world, including Europe, against the rising cost of living. The world’s reserve currencies export inflation to other countries.

What happened in 2020?

For the first time in decades, the Federal Reserve, and the main central banks increased money supply well above demand. The response to the forced shutdown of activity with massive money printing generated an unprecedented inflationary wave. The economy did not collapse due to lack of liquidity or a credit crunch, but due to the lockdowns.

The 2020 monetary tsunami launched a global boomerang effect with three consequences:

  • Emerging market currencies plummeted against the dollar because their central banks “copied” the U.S. policy without the global demand that the U.S. dollar enjoys.

  • The second effect was a disproportionate amount of money flowing to risky assets joined by more flows to take overweight positions in scarce assets. That excess money made investors move from being underweight in commodities to overweight, generating a synchronized and abrupt rally.

  • The third key factor is that extraordinary measures typical of a financial or demand crisis were taken to mitigate a supply shock, generating an unprecedented rise in money with no added credit demand. More money in scarce assets is not a price increase, but a decrease in the purchasing power of money.

What is the risk?

The history of money since the Roman Empire always tells us the same thing. First, money is aggressively printed with the excuse that “there is no inflation.” When inflation rises, central banks and governments tell us that it is “transitory” or due to “multi-casual” effects. And when it shoots up, governments present themselves as the “solution” imposing price controls and restrictive measures on exports. It is not a theory. All of us who have lived in the seventies know it.

That is why it is dangerous to pursue conglomerate stocks as an inflationary bet… Because when price controls and government intervention increases, margins collapse.

The risk of stagflation is not small, and the so-called value stocks are not a good bet in this environment. In stagflation, commodities with tight supply dynamics, gold and silver, high margin sectors and bonds of stable currencies support a portfolio. However, most sectors underperform as we saw in the 70s, where the S&P 500 generated very weak returns, significantly below inflation.

What can be different from other episodes?

Only a drastic reaction from central banks can change it. However, the question is: Will central banks tighten policy when government deficits are soaring and even a small increase in sovereign yields can generate a debt crisis?

Will they react to what is clearly — as always — a monetary inflationary process?

Tyler Durden
Wed, 05/26/2021 – 06:30

via ZeroHedge News https://ift.tt/3fKGLHx Tyler Durden

A Town in New Jersey Tried To Seize This Property To Block a Housing Development, Which Has Still Not Been Built


Screen Shot 2021-05-26 at 5.47.59 AM

Home prices keep climbing. It’s another reason to let people build housing.

But corrupt politicians sometimes prevent that.

The little town of Edgewater, New Jersey, sits right across the Hudson River from Manhattan. A developer, Maxal Group, bought a dumpsite there and proposed building more than a thousand new waterfront apartments.

The town said no.

Why? The development would generate $12 million a year in taxes for Edgewater. To please the politicians, Maxal even offered to build parks and a school at no cost.

But Edgewater Mayor Michael McPartland and his town council rejected the parks, school, and extra tax revenue.

Instead, they spent tax money on lawyers to try to seize the property using eminent domain law. They claimed they wanted to use site to park garbage trucks.

Why would they do this? So garbage could have a beautiful view of Manhattan’s skyline?

Reportedly, they did it because they wanted to please a competing developer, Fred Daibes, says Justin Walder, lawyer for the Maxal Group, in my new video.

A lawsuit he filed alleged “corrupt transactions” between Daibes and Edgewater politicians. Walder says the politicians received “undervalued rentals, loans for their business purposes through a bank that Mr. Daibes started.”

Daibes did once tell a reporter, “You can’t be in Edgewater and not be affiliated with me.”

McPartland even lived in a building owned by Daibes and paid below-market rent, said Walder.

McPartland later denied that. The mayor and city council say they denied the project because it was too big.

But “they just approved a larger project!” Walder told me.

That larger project, twice as tall as Maxal’s, was controlled by developer Daibes.

Daibes declined our requests for an interview.

Edgewater’s mayor and city council didn’t even respond to our requests.

So, I dropped in on one of their meetings.

“Are you on the take?” I asked. “Rejecting one building in favor of the one owned by the guy where you live?”

That led to awkward silence.

I continued. “Is it true that four of you are getting loans from Mr. Daibes’ bank, and is it true that you [McPartland] get a discounted apartment in Mr. Daibes’ building?”

More silence.

Then the town’s lawyer turned to the mayor and said, “As your legal counsel, I’m going to suggest and recommend that you don’t answer the question.”

The mayor didn’t. He ended the meeting.

That confrontation occurred several years ago.

After Stossel TV released video of that moment in Edgewater, McPartland issued a statement that said: “The complaint filed and the biased reporting are slanderous and defamatory to me and the other members of the council. I am somewhat constrained with what I can say, given this matter is in litigation. But I look forward to shining a light on these greedy and profit-only driven developers who are looking only to helicopter into Edgewater, overdevelop the site, and then leave with their profits.”

Two years later, he apparently changed his mind about “greedy and profit-only driven developers.” He approved a somewhat smaller version of Maxal’s plans. Maxal also agreed to transfer some land to the town for free.

In return, Maxal dropped its corruption lawsuit.

Daibes still faces unrelated conspiracy charges. But no Edgewater politician has been prosecuted for self-dealing.

The apartments that would have had views of the beautiful Manhattan skyline still haven’t been built. Maxal’s project is now held up by a new lawsuit.

It’s such a waste. There could have been waterfront apartments that more than a thousand people could enjoy.

But because a politically connected businessmen wants more for himself, and politicians have the power to demand that developers kiss their rings, Edgewater’s dump is still a dump.

DISTRIBUTED BY CREATORS.COM

from Latest – Reason.com https://ift.tt/3hQjTsZ
via IFTTT